18:42 · 24 February 2022

Moderna stock surges after upbeat quarterly results

Moderna (MRNA.US) stock rose over 10% during today's session after the vaccine maker reported solid quarterly results. 

  • The biotech company earned an adjusted $11.29 per share on $7.2 billion of revenue, easily beating market expectations of  $9.90 in earnings per share on $6.78 billion of revenue. 
  • The company’s CEO told CNBC that he thought people would need another Covid booster shot in the fall.
  • Modeerna expects at least $19 billion ofcoronavirus vaccine - Spikevax sales in 2022, with additional signed options of approximately $3 billion.
  • Company unveiled a new $3 billion share repurchase plan.

Moderna (MRNA.US) stock fell sharply in recent months, however it seems that buyers managed to halt declines around $149.60 level which coincides with 78.6% Fibonacci retracement of the upward wave launched at the beginning of 2020 and 50 SMA (green line). As long as the price sits above this level, upward move may be resumed. On the other hand, if sellers manage to regain control, then another downward impulse towards support at $56.55 may be launched. Source: xStation5

22 May 2026, 15:20

US OPEN: Wall Street Nears Record Highs Ahead of Long Weekend, Powered by AI

22 May 2026, 11:46

Market Wrap: Technology Stocks Keep European Markets Afloat💡

22 May 2026, 08:01

Hopes remain high for a US/ Iran deal, as stocks rally and bonds recover

21 May 2026, 18:19

Walmart falls despite strong earnings

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.